Sarepta Therapeutics SRPT
NASDAQ SRPT
$18.64 -0.16 (-0.85%)
At close: Sep 29, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) EV to EBIT (2024)

Updated

Sarepta Therapeutics' (SRPT) EV to EBIT was 47.81 for Q4 2024, down 63.9% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) EV to EBIT (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Sarepta Therapeutics 1.99 Bn -1.25 Bn 251.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 47.81
Sep 30, 2024 132.40
Jun 30, 2024 357.86
API Access

Sarepta Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SRPT&period=max&api_key=YOUR_API_KEY